Ion Beam Applications SA
Jean-Marc Bothy has a diverse work experience spanning from 1988 to the present. Jean-Marc began their career as an Auditor at Ernst&Young and then moved on to become a Financial Controller at IBA. Jean-Marc then transitioned to Mendez Translations, where they served as the Finance Director. Returning to IBA, they held the roles of CFO and later Chief Strategy Officer. Currently, they serve as the President of IBA Dosimetry.
From 1982 to 1987, Jean-Marc Bothy attended Ichec Brussels Management School, but there is no information available regarding the degree or field of study pursued during this time.
This person is not in any teams
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.